Please wait...
About This Project
BBRI and Los Angeles VA Medical Center
Multiple myeloma (MM) is a cancer of the bone marrow made up of plasma cells (a type of antibody-producing white blood cells). Low oxygen levels (called hypoxia) in the bone marrow increases gene expression in MM tumor cells as part of an adaptive survival response. We are targeting this hypoxic response with an experimental drug that blocks expression of these genes to ask if this molecule kills MM in the bone marrow. This is a novel approach to treat MM, an incurable disease.
More Lab Notes From This Project
Browse Other Projects on Experiment
Related Projects
Urban Pollination: sustain native bees & urban crops
Bee activity on our crop flowers is crucial to human food security, but bees are also declining around the...
Cannibalism in Giant Tyrannosaurs
This is the key question we hope to answer with this study. This project is to fund research into a skull...
Seattle HiveBio Community Lab
Thank you to everyone who has supported HiveBio thus far. As of April 17th we've reached our basic funding...